Tara Gelb
Affiliations: | 2010-2015 | Pharmacology | Georgetown University, Washington, DC |
Google:
"Tara Gelb"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Hill NT, Gelb T, Urban D, et al. (2020) Abstract 575: Disulfiram plus copper synergizes with etoposide for the treatment of Merkel cell carcinoma Cancer Research. 80: 575-575 |
| Carroll TM, Williams JS, Daily K, et al. (2017) Hedgehog signaling inhibitors fail to reduce Merkel cell carcinoma viability. The Journal of Investigative Dermatology |
| Gelb T, Pshenichkin S, Hathaway HA, et al. (2015) Atypical signaling of metabotropic glutamate receptor 1 in human melanoma cells. Biochemical Pharmacology. 98: 182-9 |
| Hathaway HA, Pshenichkin S, Grajkowska E, et al. (2015) Pharmacological characterization of mGlu1 receptors in cerebellar granule cells reveals biased agonism. Neuropharmacology. 93: 199-208 |
| Gelb T, Pshenichkin S, Rodriguez OC, et al. (2015) Metabotropic glutamate receptor 1 acts as a dependence receptor creating a requirement for glutamate to sustain the viability and growth of human melanomas. Oncogene. 34: 2711-20 |
| Gelb T, Pshenichkin S, Hathaway HA, et al. (2015) Abstract A15: mGlu1 Receptors and downstream signal transduction proteins as therapeutic targets for the treatment of metastatic melanoma Cancer Research. 75 |
| Gelb T, Hathaway HA, Wroblewski JT. (2014) Triple threat treatment: Exploiting the dependence receptor properties of metabotropic glutamate receptor 1 against melanoma. Molecular & Cellular Oncology. 1: e969163 |
| DiRaddo JO, Pshenichkin S, Gelb T, et al. (2013) Two newly identified exons in human GRM1 express a novel splice variant of metabotropic glutamate 1 receptor. Gene. 519: 367-73 |